BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24560108)

  • 1. Intrahepatic cholangiocarcinoma.
    Brown KM; Parmar AD; Geller DA
    Surg Oncol Clin N Am; 2014 Apr; 23(2):231-46. PubMed ID: 24560108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Viewpoint of systematic lymphadenectomy for intrahepatic cholangiocarcinoma patients].
    Lu W; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):247-252. PubMed ID: 30929368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
    Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
    [No Abstract]   [Full Text] [Related]  

  • 8. Case Report: Camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review.
    Zhang Z; Wang X; Li H; Sun H; Chen J; Lin H
    Front Immunol; 2023; 14():1230261. PubMed ID: 37671157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary approaches to intrahepatic cholangiocarcinoma.
    Maithel SK; Gamblin TC; Kamel I; Corona-Villalobos CP; Thomas M; Pawlik TM
    Cancer; 2013 Nov; 119(22):3929-42. PubMed ID: 23963845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
    Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
    Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress on surgical treatment of intrahepatic cholangiocarcinoma].
    Shen F; Xie ZH; Xia Y; Wu MC
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):241-246. PubMed ID: 30929367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging of intrahepatic cholangiocarcinoma.
    Nathan H; Pawlik TM
    Curr Opin Gastroenterol; 2010 May; 26(3):269-73. PubMed ID: 20179593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report.
    Lubana SS; Singh N; Seligman B; Tuli SS; Heimann DM
    Am J Case Rep; 2015 Jul; 16():438-44. PubMed ID: 26158884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors.
    Marubashi S; Gotoh K; Takahashi H; Ohigashi H; Yano M; Ishikawa O; Sakon M
    Dig Dis Sci; 2014 Jan; 59(1):201-13. PubMed ID: 24122559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of a young woman with peripheral cholangiocarcinoma: a case report.
    Marvin MR; Lefkowitch J; Ishak KG; Chabot J
    J Clin Gastroenterol; 1999 Jan; 28(1):64-6. PubMed ID: 9916672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY; Jung JC; Heo JS; Choi SH; Choi DW; Kim YI
    J Gastroenterol Hepatol; 2008 May; 23(5):766-70. PubMed ID: 17868336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.